For instance, a study in 109 children diagnosed with ALL showed that carriers of both the CYP3A5*3/*3 and GSTP1 Ile/Ile genotype displayed a lower drug clearance, although this association was only observed in African Americans one month after treatment (Kishi et al., 2004). Here, CYP3A5 is linked to acute lymphoblastic leukemia.